Prediabetes Is a Warning, Not a Prophecy

An HbA1c of 6.0% can sound alarming—but does prediabetes mean that type 2 diabetes is inevitable? In this evidence-based video, Dr. Khudr Alhamdan—Dr. Green, Consultant Endocrinologist—explains: • What prediabetes really means • How HbA1c, fasting glucose and the OGTT differ • What happens inside the body • Whether everyone with prediabetes progresses to diabetes • What the Diabetes Prevention Program discovered • Which lifestyle changes have the strongest evidence • When metformin may be considered • Why follow-up and monitoring matter The central message: Prediabetes is a warning—not a prophecy. It gives us time to act. CHAPTERS 00:00 The Question Behind the Number 00:52 A Range, Not a Switch 02:20 What Is Happening Inside the Body? 03:22 Does Everyone With Prediabetes Progress? 04:13 The Diabetes Prevention Study 05:44 What Actually Helps? 07:57 Does Everyone Need Metformin? 09:16 What Should You Do Next? 10:26 Five Myths to Leave Behind 11:17 A Signal to Act MEDICAL DISCLAIMER This video is provided for general educational purposes only. It does not provide individual medical advice, diagnosis or treatment and should not replace consultation with a qualified healthcare professional. The diagnostic thresholds discussed generally apply to nonpregnant adults. Pregnancy, recent illness, medications, kidney disease, altered red-cell turnover and certain hemoglobin variants may affect test selection or interpretation. Do not start, stop or change any medication based solely on this video. Discuss your individual results, risk factors and treatment options with your healthcare professional. SCIENTIFIC REFERENCES 1. American Diabetes Association Professional Practice Committee. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2. American Diabetes Association Professional Practice Committee. Prevention or Delay of Diabetes and Associated Comorbidities: Standards of Care in Diabetes—2026. Diabetes Care. 3. Knowler WC, et al.; Diabetes Prevention Program Research Group. Reduction in the Incidence of Type 2 Diabetes With Lifestyle Intervention or Metformin. New England Journal of Medicine. 2002;346:393–403. https://pubmed.ncbi.nlm.nih.gov/11832... 4. Diabetes Prevention Program Research Group. Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications Over 15-Year Follow-up. The Lancet Diabetes & Endocrinology. 2015;3:866–875. https://doi.org/10.1016/S2213-8587(15... 5. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetes Prevention Program (DPP). https://www.niddk.nih.gov/about-niddk... Subscribe for evidence-based medical education about diabetes, obesity, thyroid disorders, hormonal health and metabolic medicine. Dr. Khudr Alhamdan | Dr. Green Consultant Endocrinologist #Prediabetes #DiabetesPrevention #DrGreen #DrKhudr